Real world effects of COPD medications: a cohort study with validation against results from randomised controlled trials

Kevin Wing, Elizabeth Williamson, James R. Carpenter, Lesley Wise, Sebastian Schneeweiss, Liam Smeeth, Jennifer K. Quint, Ian Douglas

Source: Eur Respir J, 57 (3) 2001586; 10.1183/13993003.01586-2020
Journal Issue: March
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Kevin Wing, Elizabeth Williamson, James R. Carpenter, Lesley Wise, Sebastian Schneeweiss, Liam Smeeth, Jennifer K. Quint, Ian Douglas. Real world effects of COPD medications: a cohort study with validation against results from randomised controlled trials. Eur Respir J, 57 (3) 2001586; 10.1183/13993003.01586-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Applicability of randomized controlled trials (RCTs) results to real-life patients in COPD
Source: International Congress 2017 – Management of COPD
Year: 2017


Run-in bias in randomised trials: the case of COPD medications
Source: Eur Respir J, 49 (6) 1700361; 10.1183/13993003.00361-2017
Year: 2017



Outcomes reported on the management of COPD exacerbations: a systematic survey of randomised controlled trials
Source: ERJ Open Res, 5 (2) 00072-2019; 10.1183/23120541.00072-2019
Year: 2019



RCT Abstract - Using a smartphone application in COPD patients to increase physical activity following pulmonary rehabilitation. Results of the AMOPUR Study, a multicenter, randomized, controlled study
Source: Virtual Congress 2021 – A multidisciplinary approach to the management of chronic respiratory diseases
Year: 2021



ß-blockers in exacerbations of COPD: feasibility of a randomised controlled trial
Source: ERJ Open Res, 3 (1) 00090-2016; 10.1183/23120541.00090-2016
Year: 2017



Cost-effectiveness of self-management in asthmatics: a 1-yr follow-up randomized, controlled trial
Source: Eur Respir J 2001; 17: 206-213
Year: 2001



Effect of ADL- training for persons with COPD: A randomized controlled trial
Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD
Year: 2011


Efficacy and costs of telehealth for the management of COPD: PROMETE II, a multicentre, randomized controlled trial
Source: International Congress 2017 – New trends in pulmonary rehabilitation and chronic care
Year: 2017



Exacerbation action plans for patients with COPD and comorbidities: a randomised controlled trial
Source: Eur Respir J, 54 (5) 1802134; 10.1183/13993003.02134-2018
Year: 2019



Multidimensional assessment and targeted therapy of severe asthma: a randomised controlled trial (RCT)
Source: International Congress 2017 – Many faces of asthma assessment
Year: 2017



No gender-related bias in COPD diagnosis and treatment in Sweden: a randomised, controlled, case-based trial
Source: ERJ Open Res, 6 (4) 00342-2020; 10.1183/23120541.00342-2020
Year: 2020



Clinical effectiveness of MDI-HFA-Modulite budesonide in the treatment of asthma – meta-analysis of randomised controlled trials
Source: Eur Respir J 2006; 28: Suppl. 50, 315s
Year: 2006

A self-management programme for COPD: a randomised controlled trial
Source: Eur Respir J 2014; 44: 1538-1547
Year: 2014



Real life vs ideal life: What can we learn from clinical trials and observational studies of COPD
Source: International Congress 2019 – Putting COPD patient needs first: Time for optimizing treatment and device selection
Year: 2019

Cardiac impact of inhaled therapy in the largest randomised placebo-controlled trial in COPD history: have we reached the SUMMIT?
Source: ERJ Open Res 2016: 00055-2016
Year: 2016



Predictors of long-term smoking cessation in patients with COPD: results from a randomised controlled trial
Source: Eur Respir J, 49 (6) 1700561; 10.1183/13993003.00561-2017
Year: 2017



Medical quality control intervention for COPD patients in China: a cluster randomized, controlled trial
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020


Cost-benefit and cost-effectiveness analysis of self-management in patients with COPD - a one-year follow-up randomised, controlled trial
Source: Eur Respir J 2002; 20: Suppl. 38, 67s
Year: 2002

Clinical effect on uncontrolled asthma using a novel digital automated self-management solution: a physician-blinded randomised controlled crossover trial
Source: Eur Respir J, 54 (5) 1900983; 10.1183/13993003.00983-2019
Year: 2019



A randomized controlled trial on office spirometry in asthma and COPD in standard general practice: the SPACE Italian study
Source: Eur Respir J 2005; 26: Suppl. 49, 670s
Year: 2005